Cantex Pharmaceuticals, Inc.
- SEC CIK
- 0001374961
No open-market purchases or sales filed in the past year.
Current role at each company
- CMRX Chimerix Inc10% Owneras of Sep 16, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Cantex Pharmaceuticals, Inc. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 16, 2021 (view filing) | Sep 14 | 2 days | Cantex Pharmaceuticals, Inc.10% Owner | SSaleCommon Stock, par value $0.001 | −6.50M | $5.75 | −$37.4M | −65.0%3.50M after |